Form 8-K - Current report:
SEC Accession No. 0000912057-02-000293
Filing Date
2002-01-04
Accepted
2002-01-04 00:00:00
Documents
11
Period of Report
2001-12-13
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2067158z8-k.htm 8-K 13423
3 EXHIBIT 10.1 a2067158zex-10_1.txt EX-10.1 177408
4 EXHIBIT 10.2 a2067158zex-10_2.txt EX-10.2 59347
5 EXHIBIT 10.3 a2067158zex-10_3.txt EX-10.3 51144
6 EXHIBIT 10.4 a2067158zex-10_4.txt EX-10.4 7191
7 EXHIBIT 10.5 a2067158zex-10_5.txt EX-10.5 135609
8 EXHIBIT 10.6 a2067158zex-10_6.txt EX-10.6 74735
9 EXHIBIT 10.7 a2067158zex-10_7.txt EX-10.7 39773
10 EXHIBIT 99.1 a2067158zex-99_1.txt EX-99.1 5530
11 EXHIBIT 99.2 a2067158zex-99_2.txt EX-99.2 7449
12 EXHIBIT 99.3 a2067158zex-99_3.txt EX-99.3 7189
  Complete submission text file 0000912057-02-000293.txt   581510
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 2502446
SIC: 2834 Pharmaceutical Preparations